MOLECULAR VISION LIMITEDActive
Key figures
Like most small UK companies, MOLECULAR VISION LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Profit for the year | -102,219 | -90,289 | -100,158 | -133,875 | — |
| Cash at bank and in hand | 66,053 | 66,748 | 68,170 | 70,828 | — |
| Total assets | — | 93,518 | 113,654 | 74,579 | — |
| Total liabilities | — | — | 1,954,918 | 2,049,718 | — |
| Net assets / total equity | -1,666,017 | -1,756,306 | -1,841,264 | -1,975,139 | -2,062,247 |
| Average number of employees | 1 | 1 | 2 | 1 | 0 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025The principal activity of the company changed during the year from that of research and experimental development on natural sciences and engineering to that of a holding Company for intellectual property for the Abingdon Health Plc group of which it is part of.
As described in the company's latest filed accounts.
Summary: MOLECULAR VISION LIMITED
Company
MOLECULAR VISION LIMITED is a private limited company registered with Companies House under company number 04292847. It was incorporated on 24 Sep 2001. Its status is active. The registered office is in York (YO41). Its nature of business (SIC 2007) is other research and experimental development on natural sciences and engineering (72190).
Accounts
The latest accounts in the database are for 2024/25 (period ending 30 Jun 2025); the company files full accounts. Net assets were −£2,062,247, down 4.4% on the previous year. The company had an average of 0 employees. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered. 1 of 2 registered charges are outstanding.
Filing deadlines
The next accounts are due by 31 Mar 2027. The next confirmation statement is due by 8 Oct 2027.